4 unchanged sentences
EXHIBIT NUMBER
−Removed: Research Funding and Option Agreement, dated March 17, 2023, between the Company and the Scripps Research Institute.
+Added: Certificate of Change to Articles of Incorporation , filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 12, 2023.
Certification of Jeffrey F.
3 unchanged sentences
Eisenberg, Principal Executive Officer, and James Parslow, Principal Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in inline XBRL, include:
+Added: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in inline XBRL, include:
(i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Stockholders’ Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) the Notes to the Condensed Consolidated Financial Statements.
−Removed: Cover Page Interactive Data File (formatted in XBRL and included in Exhibit 101).
+Added: Cover Page Interactive Data File (formatted in inline XBRL and included in Exhibit 101)
Filed herewith.
Exhibit 32.1 is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended, except as otherwise stated in such filing.
−Removed: Portions of this exhibit, marked by brackets and asterisks, have been omitted pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act of 1933, as amended, because they are both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.
−Removed: The registrant undertakes to promptly provide an unredacted copy of the exhibit on a supplemental basis, if requested by the Commission or its staff.
Pursuant to the requirements
2 unchanged sentences
Xenetic Biosciences, Inc.
+Added: August 10, 2023
/S/ JEFFREY F.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.